News Release

Rohto Group's proprietary material "Globin Proteolysate (Metap®)" has been confirmed to have a "liver-protecting effect" in people who drink alcohol or have high triglycerides.

We have launched "Vision R ~Sprinkle It~," a sprinkle-type multivitamin supplement containing 13 types of vitamins and minerals.

We have signed a strategic partnership agreement with TNM Digital Inc.

Experience "The Future Society of 2050 Where Regenerative medicine is Accessible" at the Osaka Healthcare Pavilion at the Osaka-Kansai Expo.

We have jointly developed a supportive voice dialogue AI with PKSHA and have begun verification for social implementation.

Research results will be presented at the 34th International Federation of Societies of Cosmetic Chemists (IFSCC) Iguazu Congress 2024

On October 10th, in conjunction with Eye Care Day and Toto (Fish) Day, ROHTO RECIPE began selling collaborative menu items designed to "energize your eyes."

We have launched a new Animal Origin Free (AOF) medium for extracellular vesicle (EV) production, "StemNavi™," which does not contain any animal or human-derived components.

October 10th is "Eye Care Day." Rohto Pharmaceutical's "Survey on Eye Frailty" shows a rapid change starting in people in their 40s!

“AutoloGel System,” a wound treatment system for refractory wounds, now covered by Japan’s National Health Insurance